載入...
Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
Patient preference is key for medication selection in chronic medical conditions, like type 2 diabetes, where there are many different drugs available. Patient preference balances potential efficacy with potential side effects. As both aspects of drug response can vary markedly between individuals t...
Na minha lista:
| 發表在: | Nat Med |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2023
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614215/ https://ncbi.nlm.nih.gov/pubmed/36477734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-022-02121-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|